Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 2
2007 1
2008 1
2010 1
2012 1
2014 2
2015 3
2016 2
2017 2
2018 1
2020 1
2021 3
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
Tassi E, Bergamini A, Wignall J, Sant'Angelo M, Brunetto E, Balestrieri C, Redegalli M, Potenza A, Abbati D, Manfredi F, Cangi MG, Magliacane G, Scalisi F, Ruggiero E, Maffia MC, Trippitelli F, Rabaiotti E, Cioffi R, Bocciolone L, Candotti G, Candiani M, Taccagni G, Schultes B, Doglioni C, Mangili G, Bonini C. Tassi E, et al. Among authors: taccagni g. Front Immunol. 2023 Oct 4;14:1212444. doi: 10.3389/fimmu.2023.1212444. eCollection 2023. Front Immunol. 2023. PMID: 37868997 Free PMC article.
Myxoid leiomyosarcoma of the ovary: a very uncommon finding.
Sant'Angelo M, Bartolucci A, Bocciolone L, Taccagni G. Sant'Angelo M, et al. Among authors: taccagni g. Int J Gynecol Cancer. 2023 Sep 1:ijgc-2022-004254. doi: 10.1136/ijgc-2022-004254. Online ahead of print. Int J Gynecol Cancer. 2023. PMID: 37657819 No abstract available.
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
Magliacane G, Brunetto E, Calzavara S, Bergamini A, Pipitone GB, Marra G, Redegalli M, Grassini G, Rabaiotti E, Taccagni G, Pecciarini L, Carrera P, Mangili G, Doglioni C, Cangi MG. Magliacane G, et al. Among authors: taccagni g. Cancers (Basel). 2022 Dec 21;15(1):43. doi: 10.3390/cancers15010043. Cancers (Basel). 2022. PMID: 36612041 Free PMC article.
Biomarker characterization in endometrial cancer in Italy: first survey data analysis.
Zannoni GF, Santoro A, D'Alessandris N, Scaglione G, Inzani F, Angelico G, Bragantini E, Piermattei A, Cianfrini F, Bisaro B, Fassan M; Members of PAGINE (SIAPEC) - Collaborators. Zannoni GF, et al. Pathologica. 2022 Jun;114(3):189-198. doi: 10.32074/1591-951X-775. Pathologica. 2022. PMID: 35775705 Free PMC article.
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness.
Bezzi C, Bergamini A, Mathoux G, Ghezzo S, Monaco L, Candotti G, Fallanca F, Gajate AMS, Rabaiotti E, Cioffi R, Bocciolone L, Gianolli L, Taccagni G, Candiani M, Mangili G, Mapelli P, Picchio M. Bezzi C, et al. Among authors: taccagni g. Cancers (Basel). 2023 Jan 3;15(1):325. doi: 10.3390/cancers15010325. Cancers (Basel). 2023. PMID: 36612321 Free PMC article.
32 results